| 000 | 02383nam a2200337 c 4500 | ||
|---|---|---|---|
| 988 | _aSpringer_BiomedLife_2019 | ||
| 999 |
_c115558 _d115558 _x1 |
||
| 001 | 115558 | ||
| 003 | ESmaUEC | ||
| 005 | 20230104140050.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 190617s2019 xxua o |||| 0|eng d | ||
| 020 | _a9781461466130 | ||
| 024 | 7 |
_a10.1007/978-1-4614-6613-0 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC268.4 _b2019 EB |
|
| 245 | 0 | 0 |
_aCancer Therapeutic Targets _cedited by John L. Marshall. |
| 264 | 1 |
_aNew York _bSpringer International Publishing _c2019 |
|
| 300 |
_a1 recurso en línea (800 páginas) _b 164 ilustraciones, 64 ilustraciones a color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aBiomedical and Life Sciences (Springer-11642) | |
| 520 | 3 | _aIn the past decade, we have experienced an explosion of new information about cancer therapeutic targets. Many of the targets have been validated by the discovery and approval of new medicines which have been approved for the treatment of cancer. On the heels of these successes, innumerable new targets and new potential therapeutics are being developed by many different groups including government agencies, pharmaceutical companies, biotechnology companies, academic institutions, and individual investigators. Understanding the expanding "universe" of cancer therapies is therefore becoming impossible and no single source exists which serves as a reference for the involved parties. Further, the interested parties have vastly different areas of expertise, from focused laboratory based science, to clinical research, to corporate and regulatory oversight. The text would be updated every two years, more often depending on pace of change, interest and sales. While useful online, this reference book would likely be kept in hard copy as well. | |
| 650 | 7 |
_2embne _9273952 _aCáncer _xAspectos genéticos |
|
| 700 | 1 |
_aMarshall, John L _eeditor _4http://id.loc.gov/vocabulary/relators/edt |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-4614-6613-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_aSI _cm _dz _feng _ggw _h0 _b12/2019 _ek _zSI |
||